SalvaRx Group plc announced final audited consolidated earnings results for the year ended December 31, 2016. For the year, the company reported operating loss of £2,447,000 compared to £481,000 a year ago. Loss before tax was £2,476,000 compared to £481,000 a year ago. Loss and comprehensive loss attributable to equity holders of the parent was £2,038,000 or 0.06 pence per basic and diluted share compared to £326,000 or 001 pence per basic and diluted share a year ago. Net cash outflow from operating activities was £1,505,000 compared to £373,000 a year ago.